Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection

Research output: Contribution to journalArticle

Abstract

Treatment of severe psoriasis (PsO) in organ transplant (OT) patients is difficult. In fact, systemic drugs used for PsO therapy can be detrimental to transplanted organs and/or can increase the risk of serious infections in subjects already taking antireject medicines. Current guidelines fail to give indications on how to manage PsO OT subjects. Moreover, only a few cases of patients with the above-cited characteristics treated with systemic therapies have been published so far. Here, we report our experience concerning a liver transplant patient successfully treated with ixekizumab for his psoriasis throughout 1 year.

Original languageEnglish
Article numbere12909
JournalDermatologic Therapy
Volume32
Issue number3
DOIs
Publication statusPublished - May 1 2019

Keywords

  • ixekizumab
  • organ transplant
  • psoriasis

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection'. Together they form a unique fingerprint.

  • Cite this